How to Cite
摘要
介绍
胰腺囊性肿瘤的鉴别诊断由于其结构特征仍然是一个复杂的挑战。胰腺液作为一种高度特异性的介质，包含细胞成分和潜在的分子标志物，因而备受关注。本研究介绍了一种新型的主动十二指肠吸取液体活检（DALB）方法，可用于收集胰腺液和胆汁的混合物。
研究目的
评估原始 DALB 技术与标准诊断方法相结合的有效性。
材料与方法
对接受了一系列标准诊断程序但未能获得明确诊断的患者进行 DALB。收集的吸取液进行细胞学分析，并测量癌胚抗原（CEA）水平。
研究结果
本研究共纳入 6 例不同类型的胰腺囊性肿瘤患者，结果表明 DALB 可与标准验证程序结合使用。获取的 CEA 水平和细胞学检测结果使得准确诊断成为可能，并指导了合理的治疗调整。
结论
本研究经验表明，DALB 技术安全有效，可应用于不同的医疗环境（门诊或住院），并有潜力提高胰腺癌的早期诊断率
参考
Cho J., Petrov M.S. Pancreatitis, pancreatic cancer, and their metabolic sequelae: Projected burden to 2050. Clinical and Translational Gastroenterology. 2020; 11(11): e00251.-DOI: https://doi.org/10.14309/ctg.0000000000000251.
Cronin K.A., Scott S., Firth A.U., et al. Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer. 2022; 128(24): 4251-4284.-DOI: https://doi.org/10.1002/cncr.34479.
NCCN guidelines ver.1.2024. Pancreatic adenocarcinoma.-URL: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf.
Goggins M., Overbeek K.A., Brand R., et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020; 69(1): 7-17.-DOI: https://doi.org/10.1136/gutjnl-2019-319352.
Ohtsuka T., Fernandez-Del Castillo C., Furukawa T., et al. International evidence-based Kyotoguidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024; 24(2): 255-270.-DOI: https://doi.org/10.1016/j.pan.2023.12.009.
Zerboni G., Signoretti M., Crippa S., et al. Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals. Pancreatology. 2019; 19(1): 2-9.-DOI: https://doi.org/10.1016/j.pan.2018.11.014.
Terasawa H., Matsumoto K., Tanaka T., et al. Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications including needle tract seeding. Pancreatology. 2023; 23(8): 988-995.-DOI: https://doi.org/10.1016/j.pan.2023.10.018.
Levink I.J.M., Visser I.J., Koopmann B.D.M., et al. Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. Gastrointest Endosc. 2022; 96(5): 801-813.e2.-DOI: https://doi.org/10.1016/j.gie.2022.04.1342.
Sadakari Y., Kanda M., Maitani K., et al. Mutant KRAS and GNAS DNA concentrations in secretin-stimulated pancreatic fluid collected from the pancreatic duct and the duodenal lumen. Clin Transl Gastroenterol. 2014; 5: e62.-DOI: https://doi.org/10.1158/1078-0432.CCR-17-2463.
Kashintsev A.A. inventor; PANDX LTD., assignee. Catheter and method for isolating a region in a hollow organ of a mammal, and system based on the catheter, and use of the catheter. Patent WO2021137739. 2021; Oct 28.-URL: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021137739&_cid=P10-LRRSSJ-50103-1.
Заитова Я.О., Кашинцев А.А., Коханенко Н.Ю., et al. Энтеральное питание в лечении острого панкреатита. Медицина: теория и практика. 2023; 8(4): 97-107.-DOI: https://doi.org/10.56871/MTP.2023.41.16.013. [Zaitov Ya.O., Kashintsev A.A., Kokhanenko N.Yu., et al. Enteral feeding in treatment of acute pancreatitis. Medicine: theory and practice. 2023; 8(4): 97-107.-DOI: https://doi.org/10.56871/MTP.2023.41.16.013 (In Rus)].
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2025